Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer Therapy
Macromolecular Bioscience · 2023
DOI: 10.1002/mabi.202300215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, 2023. Verfasst von Meng He und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory of Electrical Insulation…. Hauptthemen laut MEDLINE: Ferroptosis, Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Ferroptosis is a novel type of iron‐dependent non‐apoptotic pathway that regulates cell death and shows unique mechanisms including causing lipid peroxide accumulation, sensitizing drug‐resistant cancers, priming immunity by immunogenic cell death, and cooperatively acting with other anticancer modalities for eradicating aggressive malignancies and tumor relapse. Recently, there has been a great deal of effort to design and develop anticancer biocompatible polymeric nanoplatforms including polypeptide and PEGylated ones to achieve effective ferroptosis therapy (FT) and synergistic combination therapies including chemotherapy (CT), photodynamic therapy (PDT), sonodynamic therapy (SDT), photothermal therapy (PTT), gas therapy (GT) including nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S), and immunotherapy (IT). To be noted, the combo therapies such as FT‐CT, FT‐PTT, FT‐GT, and FT‐IT are attracting much efforts to fight against intractable and metastatic tumors as they can generate synergistic antitumor effects and immunogenic cell death (ICD) effects or modulate immunosuppressive tumor microenvironments to initiate strong antitumor immunity and memory effects. The polymeric Fenton nano‐agents with good biosafety and high anticancer efficacy will provide a guarantee for their applications. In this review, various biocompatible polymer‐modified nanoplatforms designed for FT and combo treatments are summarized for anticancer therapies and discussed for potential clinical transitions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory of Electrical Insulation and Thermal Aging, Shanghai Jiao Tong University, Shanghai, 200240, P…
- Shanghai Public Health Clinic Center, Fudan University, Shanghai, 201508, P. R. China.
ORCID-Profile: Chang-Ming Dong
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
He, M., Dan, Y., Chen, M., & Dong, C. M. (2023). Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer Therapy. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202300215
Vancouver
He M, Dan Y, Chen M, Dong CM. Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer Therapy. Macromolecular Bioscience. 2023. doi:10.1002/mabi.202300215
BibTeX
@article{He2023,
author = {He, Meng and Dan, Yuxin and Chen, Mingsheng and Dong, Chang-Ming},
title = {Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer Therapy},
journal = {Macromolecular Bioscience},
year = {2023},
doi = {10.1002/mabi.202300215}
}
EUVIMED